Connect with us
DAPA Banner

Business

CVS Health Stock Surges 7% on Positive Medicare Outlook as Turnaround Gains Momentum

Published

on

FTSE 100 Surges 0.8% Today as Oil Eases and Markets

CVS Health Corp. shares jumped more than 6% in morning trading Tuesday, climbing to $78.19, up $4.92 or 6.71%, as investors cheered fresh optimism around Medicare Advantage payments and the company’s ongoing turnaround efforts in a challenging health care environment.

FTSE 100 Surges 0.8% Today as Oil Eases and Markets

The NYSE-listed stock (CVS) rallied on reports that the Centers for Medicare & Medicaid Services finalized 2027 Medicare Advantage rates in a manner viewed as more favorable than feared, easing concerns that had weighed on the sector. The move marked the fourth straight day of gains for CVS and pushed shares toward the upper end of their recent trading range.

Analysts described the reaction as a relief rally for a stock that has faced persistent pressure from margin compression in its insurance business, regulatory scrutiny and a broader reset in managed care valuations. With Q1 2026 earnings set for release on May 6, the Tuesday surge reflected growing confidence that CVS is stabilizing its Aetna health insurance segment while leveraging its massive pharmacy and retail footprint.

CVS Health, one of the nation’s largest health care companies, operates roughly 9,000 retail pharmacies, more than 1,000 clinics and a leading pharmacy benefits manager serving about 87 million plan members. It also provides health insurance coverage to millions through Aetna, including highly rated Medicare Advantage plans.

The company has been executing a multi-year turnaround plan aimed at improving margins, simplifying operations and using technology — including artificial intelligence — to better integrate its pharmacy, insurance and clinical services. Executives have highlighted progress in lowering drug prices, enhancing care navigation and positioning CVS as “the front door of care” for millions of Americans.

Advertisement

In February, CVS reported fourth-quarter 2025 results that beat Wall Street expectations on both revenue and earnings. The company reaffirmed its full-year 2026 guidance, projecting adjusted earnings per share of $7.00 to $7.20 and revenue of at least $400 billion. It also maintained GAAP diluted EPS guidance of $5.94 to $6.14.

“Our fourth quarter and full-year results demonstrate the progress we are making in transforming the health care experience,” CEO David Joyner said at the time. The company noted steady performance in its pharmacy and consumer wellness segment, which helped offset pressures in the health insurance business.

Analysts largely view CVS as undervalued. The consensus 12-month price target from roughly two dozen Wall Street firms sits near $95, implying potential upside of more than 20% from current levels. Ratings skew heavily toward Buy or Moderate Buy, with no Sell recommendations in recent coverage. Some bullish voices see shares reaching the mid-$100s if Medicare Advantage margins recover as expected and cost-cutting initiatives deliver.

The stock has traded in a 52-week range roughly between the mid-$50s and mid-$80s, reflecting volatility tied to insurance sector headwinds and broader economic uncertainty. Despite the challenges, CVS has maintained a healthy dividend, recently declaring a quarterly payout of $0.665 per share, payable May 4 to shareholders of record on April 23.

Advertisement

Tuesday’s gains came as the broader health care sector showed mixed performance, with several managed care peers also rising on the Medicare news. Investors appeared to price in expectations of improved medical benefit ratios and more stable membership trends in CVS’s insurance business.

Turnaround Plan Shows Early Signs of Success

CVS has focused on several pillars in its recovery strategy. These include optimizing its pharmacy benefit manager operations, expanding clinical services through its retail clinics and MinuteClinic locations, and investing in digital tools that connect patients, payers and providers more seamlessly.

The company has faced scrutiny over insulin pricing and other pharmacy practices, reaching a proposed settlement with the Federal Trade Commission in March. It has also navigated antitrust concerns and ongoing litigation related to its business practices.

Still, executives have expressed confidence that 2026 will mark continued improvement. The reaffirmed guidance projects margin expansion across segments even as overall revenue growth remains relatively modest. Cash flow from operations is expected to reach at least $9 billion.

Advertisement

Analysts at firms such as Seeking Alpha contributors and major banks have highlighted CVS’s attractive valuation metrics — trading at a forward price-to-earnings multiple in the low teens and a price-to-sales ratio near 0.25. Some argue the market has overly penalized the stock for near-term insurance pressures while underappreciating the long-term strength of its diversified model.

“Stop catastrophizing and start believing,” one analysis suggested, pointing to potential for more than 50% upside if Medicare margins normalize and the company executes on its integration plans.

Upcoming Earnings in Focus

Attention now turns to the May 6 earnings release and conference call. Investors will look for updates on same-store sales trends in retail pharmacy, membership changes in Medicare Advantage, progress on cost controls and any commentary on the competitive landscape.

CVS has been expanding its offerings, including new pharmacy-only locations and enhanced primary care services. It continues to invest in technology platforms that aim to create a more unified consumer experience, potentially driving customer loyalty and higher-margin services.

Advertisement

Broader industry challenges persist. Rising medical costs, regulatory changes and competition from other pharmacy chains and telehealth providers remain risks. CVS must also manage its significant debt load while funding growth initiatives and returning capital to shareholders through dividends and potential buybacks.

Despite these headwinds, many see CVS as well-positioned for a multi-year recovery. Its scale — touching millions daily through pharmacies, clinics and insurance — provides a resilient foundation. The integrated model allows the company to capture value across the health care spectrum, from filling prescriptions to managing chronic conditions to providing insurance coverage.

Dividend Appeal and Shareholder Returns

The quarterly dividend offers a yield that remains attractive for income-focused investors. With the ex-dividend date approaching later this month, some buying may reflect positioning for the payout.

CVS has a long history of returning capital to shareholders, though it has moderated share repurchases in recent years to prioritize balance sheet strength amid the turnaround.

Advertisement

As trading continued Tuesday, volume was elevated as the stock tested resistance levels near $78-$80. Options activity showed increased interest in calls, reflecting bullish sentiment around the Medicare developments and upcoming earnings.

For long-term investors, CVS represents a bet on America’s aging population and the enduring demand for accessible pharmacy and health services. Success hinges on improving profitability in its insurance arm while defending its dominant position in retail pharmacy amid shifting consumer habits and competitive pressures.

The company, headquartered in Woonsocket, employs hundreds of thousands and operates one of the most extensive health care networks in the United States. Its brands — including CVS Pharmacy, Aetna and Omnicare — are household names.

Tuesday’s surge provided a positive note after periods of relative underperformance. Whether the momentum sustains will depend on execution in the coming quarters and any surprises in the May earnings report.

Advertisement

Analysts caution that while the setup looks increasingly favorable, CVS must deliver consistent results to rebuild investor confidence fully. Regulatory and reimbursement risks in Medicare could still create volatility.

For now, the market appears to be rewarding signs that the worst of the pressures may be easing and that the turnaround plan is gaining traction. With shares still trading well below analyst targets, some see the current levels as an attractive entry point for those bullish on health care’s long-term fundamentals.

As the session progressed, CVS Health stood out as one of the stronger performers in the health care sector, underscoring Wall Street’s renewed appetite for beaten-down names showing operational progress.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Yen jumps sharply as Japan warns it is ready to intervene again

Published

on

Yen jumps sharply as Japan warns it is ready to intervene again


Yen jumps sharply as Japan warns it is ready to intervene again

Continue Reading

Business

Adamas Trust, Inc. 2026 Q1 – Results – Earnings Call Presentation (NASDAQ:ADAM) 2026-05-01

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q1: 2026-04-29 Earnings Summary

EPS of $0.29 beats by $0.06

 | Revenue of $48.41M (46.27% Y/Y) misses by $1.17M

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Advertisement
Continue Reading

Business

Bayer recalls nearly 800,000 Afrin bottles over child safety risk

Published

on

Bayer recalls nearly 800,000 Afrin bottles over child safety risk

Bayer issued a recall for nearly 800,000 units of Afrin nasal spray bottles after the packaging was found to be not child resistant on Thursday.

The U.S. Consumer Product Safety Commission (CPSC) announced the recall Thursday, saying any customers who purchased the product are entitled to a refund. The recall impacts 786,100 units of the 6ml travel-size Afrin nasal spray.

Advertisement

“This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have ‘Afrin® Original Nasal Spray’ and ‘1/5 FL OZ (6 mL)’ printed on a label located on the front of the bottle,” the CPSC recall reads.

“The 6 mL nasal spray’s packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning if the contents are swallowed by young children,” the statement added.

BEEF STICKS FOOD PRODUCT RECALLED FOR ‘PIECES OF METAL’ FOUND INSIDE

Afrin recall

The CSPC issued a recall for Afrin nasal spray. (CSPC)

No injuries have been reported in connection with the recall.

Advertisement

The news comes just a day after nearly 13,000 toddler towers across three brands were recalled after dozens of incidents and 21 injuries were reported due to stools collapsing or tipping, according to the CPSC.

The three affected products — Toetol Tower Stools, Wiifo Children’s Tower Stools and Amzcmj DGD Children’s Tower Stools — total about 12,830 stools, according to notices from the Consumer Product Safety Commission.

CHOCOLATE-COVERED SNACK PRODUCT SOLD IN 16 STATES RECALLED FOR POTENTIALLY UNDECLARED ALMONDS AND CASHEWS

Recalled toddler stools

Toetol Tower Stools, Wiifo Children’s Tower Stools and Amzcmj DGD Children’s Tower Stools (Consumer Product Safety Commission)

The recall covers about 3,000 Toetol Tower Stools, 9,700 Wiifo Children’s Tower Stools and 130 Amzcmj DGD Children’s Tower Stools.

Advertisement

“The recalled tower stools can collapse or tip over while in use and a child’s torso can fit through the openings on the tower’s sides, posing a risk of serious injury and death due to tip over, fall and entrapment hazards,” the notices read.

For the Toetol Tower Stools, there have been 18 reports of the stools collapsing, resulting in 11 injuries, including contusions, cuts and scrapes.

CLICK HERE TO GET FOX BUSINESS ON THE GO

The wooden kitchen tower step stools were sold in white, gray and dark wood colors and measure about 20 inches deep, 15 inches wide and 36 inches tall with model DETD0001 printed on a label on the side. They were sold online on Amazon from October 2024 through March 2026 for about $130.

Advertisement
Continue Reading

Business

SP Group A/S 2026 Q1 – Results – Earnings Call Presentation (OTCMKTS:SPGGF) 2026-05-01

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Continue Reading

Business

Hertz, Uber partner to build robotaxi fleets in major mobility push

Published

on

Hertz, Uber partner to build robotaxi fleets in major mobility push

Hertz is expanding beyond its traditional car rental business through a new partnership with Uber aimed at powering both autonomous robotaxi fleets and driver-led rideshare operations, signaling a broader shift in the transportation industry.

Under the agreement, Hertz’s newly launched unit, Oro Mobility, will manage vehicle operations for Uber, including maintenance, charging, cleaning and logistics for autonomous vehicles. 

Advertisement

The robotaxi service, which will use Lucid vehicles equipped with Nuro self-driving technology, is expected to launch in the San Francisco Bay Area later this year, with potential “expansion opportunities” in 2027.

Hertz will also supply and operate fleets of vehicles driven by its own employees on Uber’s platform, building on a pilot program that has already expanded into Los Angeles and San Francisco with additional markets planned.

UBER, RIVIAN INK $1.25B DEAL TO PUT THOUSANDS OF ROBOTAXIS ON US STREETS

A Lucid Gravity robotaxi.

A Lucid Gravity autonomous taxi at the first National AV Safety Forum held by the National Highway Traffic Safety Administration at the Department of Transportation headquarters in Washington, D.C., March 10, 2026. (Alex Kent/Bloomberg via Getty Images)

The partnership highlights a shift in the ridesharing model away from individual car ownership toward centrally managed fleets. Hertz is positioning itself as a transportation infrastructure provider, leveraging its expertise in large-scale vehicle logistics and maintenance.

Advertisement
Ticker Security Last Change Change %
UBER UBER TECHNOLOGIES INC. 74.61 +0.14 +0.19%
HTZ HERTZ GLOBAL 6.36 +0.76 +13.57%

Uber, meanwhile, is continuing to emphasize a platform-driven model, relying on partners like Hertz to manage fleet operations as it scales both human-driven and autonomous rides.

For Hertz, the deal represents a high-stakes bet on a new growth strategy after years of turbulence, while, for Uber, it marks another step toward a hybrid network that could eventually integrate human drivers with self-driving vehicles at scale.

An Uber sign.

Uber is continuing to emphasize a platform-driven model. (Smith Collection/Gado/Getty Images)

CLICK HERE TO GET FOX BUSINESS ON THE GO

“Partnering with Hertz’s Oro Mobility will help us continue to bring the best autonomous technology onto the Uber platform and accelerate the transition to a hybrid network in which both driver-led and autonomous rideshare operations can scale and serve communities reliably and efficiently,” Uber’s Andrew Macdonald said in a statement. 

Advertisement

“By combining Uber’s global platform and marketplace leadership with Oro’s dedicated fleet management expertise, we are well-equipped to meet increasing rideshare demand and deliver a seamless, high-quality rider experience across the entire mobility ecosystem.”

Continue Reading

Business

Heating oil prices rose by 92% in March

Published

on

Heating oil prices rose by 92% in March

Data suggests prices peaked on 8 April when 500 litres cost an average of £627.

Continue Reading

Business

Build-A-Bear recalls 36,000 weighted bears over zipper choking hazard

Published

on

Build-A-Bear recalls 36,000 weighted bears over zipper choking hazard

About 36,000 Build-A-Bear plush bears are being recalled due to a potential choking hazard, the U.S. Consumer Product Safety Commission (CPSC) announced Thursday.

The recall involves the Heartwarming Hugs weighted plush bear, which features a side pouch containing a heart filled with 2.5 pounds of ceramic beads that can be heated or cooled.

Advertisement

According to the CPSC, the pouch is secured with a zipper, but the zipper slider can detach, posing a choking hazard.

No injuries have been reported, but one incident in the United Kingdom involved the zipper slider detaching, the agency said.

COCAINE AND FENTANYL FOUND HIDDEN INSIDE BARBIE DOLL PACKAGING SOLD TO CUSTOMERS, POLICE SAY

A close-up of a Build-A-Bear plush bear

A close-up of a Build-A-Bear plush bear included in a recall after officials warned a zipper component could pose a choking hazard. (U.S. Consumer Product Safety Commission / Unknown)

“The safety and wellbeing of our guests and their families is our highest priority,” Build-A-Bear said in a statement. “Out of an abundance of caution, consumers should immediately stop using the recalled Heartwarming Hugs Bear and return it to a local Build-A-Bear Workshop store to receive a refund in the form of the original payment or a gift card for the purchase price.”

Advertisement

The product is intended for ages 3 and up and includes a cautionary label advising adult supervision due to the heated and cooled element.

The bears were sold at Build-A-Bear Workshop stores and online beginning in January for about $48.

NEARLY 13K TODDLER TOWERS RECALLED AFTER DOZENS OF INJURIES FROM STOOLS COLLAPSING, TIPPING

Build-A-Bear External Shop Signage

Build-A-Bear external store sign.  (Peter Dazeley/Getty Images)

The recall involves model number 034464, which can be found sewn into the back of the bear’s leg.

Advertisement

Consumers are urged to stop using the recalled bears immediately and return them to a Build-A-Bear Workshop store for a refund.

Customers who cannot visit a store can request a free return shipping label through the company’s website.

CLICK HERE TO GET FOX BUSINESS ON THE GO

child holding a teddy bear

A recall has been issued for certain Build-A-Bear plush toys over a potential choking hazard. (Enrico Mattia Del Punta/NurPhoto / Getty Images)

Build-A-Bear can be reached at 844-541-0144 or by email at ProductHotline@buildabear.com. More information is available on the company’s website under its recall section.

Advertisement
Continue Reading

Business

Square Yards reports Rs 2,086 crore revenue in FY26, growth of 48% year-over-year

Published

on

Square Yards reports Rs 2,086 crore revenue in FY26, growth of 48% year-over-year
Real estate platform Square Yards has reported a revenue of Rs 2,086 crore (USD 223 million), with 48% year-over-year growth in FY26. The company’s EBITDA increased to Rs 176 crore, a 3.7x jump year-over-year, with EBITDA margins expanding from 3% to 8%.

It’s gross profit reached Rs 476 crore (USD 51 million), growing 49% Y-Y, with gross margins sustained at 23% on a significantly larger revenue base.

India revenue grew 57% Y-Y vs 48% overall, with India now contributing 88% of total revenue while International (GCC + ROW) contributes the balance 12%.

“Even with the scale, we are still operating at low single digit market share and that allows us room to think beyond the next 5 years of growth,” said Tanuj Shori, Founder and CEO, Square Yards.

Advertisement

Square Yards facilitated over 2,73,643 customer acquisitions in FY26.


Bangalore leads real estate GTV share at 30%, followed by Mumbai (19%), Delhi NCR (11%), Pune (10%), and Hyderabad (6%). International (Global Real Estate) contributed 21% of GTV.
Square Yards’ fintech arm Urban Money reported a total GTV of Rs 87,831 crore in FY26, with mortgage loans commanding 86% share. Non-mortgage products contribute the remaining 14%, spread across business loans (6%), personal loans (4%), and others (4%), indicating early but meaningful diversification.

Continue Reading

Business

Strait of Hormuz Blockade Persists Amid US-Iran Standoff, Sending Oil Prices Soaring

Published

on

Strait of Hormuz Traffic Near Standstill Despite US-Iran Ceasefire: Only

DUBAI, United Arab Emirates — Nearly two months into the 2026 Iran conflict, the Strait of Hormuz remains effectively closed to most commercial traffic as a US naval blockade clashes with Iranian threats, driving oil prices above $120 per barrel and stranding thousands of seafarers while threatening global energy security.

Strait of Hormuz Traffic Near Standstill Despite US-Iran Ceasefire: Only
Strait of Hormuz

The narrow waterway, through which roughly 20% of the world’s oil and liquefied natural gas typically flows, has seen traffic drop to a fraction of normal levels since late February when US and Israeli strikes on Iran triggered Iranian retaliation and a shutdown of the chokepoint. Despite diplomatic efforts and a fragile conditional ceasefire, shipping remains severely restricted, with only limited passages for vessels from “non-hostile” nations.

US President Donald Trump has signaled the blockade on Iranian ports will continue until safe passage through the strait is guaranteed, while floating ideas such as a maritime coalition to reopen the route. Iran has responded defiantly, with officials warning of “long and painful strikes” against US positions if attacks resume and maintaining control over the waterway. Supreme Leader Mojtaba Khamenei and other Iranian figures have vowed not to cede sovereignty.

Recent incidents have heightened tensions. Iranian forces have seized vessels, including reports of attacks on ships attempting transit, while the US has conducted operations against Iranian-linked shipping. At least a dozen commercial vessels transited the strait in recent 24-hour periods, but overall volume remains minimal compared to pre-crisis levels of thousands per month.

The economic fallout has been swift and severe. Benchmark oil prices surged on fears of prolonged disruption, though some retreat occurred as alternative routes and stockpiles provided limited relief. Global supply chains for energy, fertilizers and other goods face strain, with insurance premiums for the region skyrocketing and shipping companies rerouting at significant cost. The United Nations has warned of humanitarian impacts, with seafarers stranded and aid deliveries complicated.

Advertisement

Analysts describe the strait as a high-stakes leverage point in the broader conflict. Iran’s ability to threaten or disrupt passage has long been a strategic deterrent, but the current blockade and counter-measures have created a dangerous standoff. Pakistan-mediated talks continue, with reopening the strait a central demand, yet mutual distrust and military posturing have stalled progress.

Maritime security experts highlight risks from mines, drones, small boats and miscalculation. The International Maritime Organization and other bodies have urged de-escalation, noting that ships and crews have become unintended pawns in geopolitical disputes. Dozens of vessels remain anchored or diverted in the Persian Gulf, with thousands of seafarers affected.

For energy markets, the crisis underscores the vulnerability of critical chokepoints. While US oil exports have hit records and alternative suppliers have increased output, prolonged closure could trigger broader shortages, particularly in Asia. European and other importers also face higher costs and logistical challenges.

Regional actors navigate complex positions. Gulf states balance relations with the US and concerns over escalation, while China and others with interests in Iranian oil seek diplomatic solutions. A Russian-linked superyacht reportedly transited the area recently, highlighting selective allowances amid the chaos.

Advertisement

Military analysts caution that forcibly reopening the strait would require significant resources and carry high risks of escalation. US officials have discussed coalition-building for “maritime freedom,” but allied enthusiasm varies. Iran’s diminished naval capacity is offset by asymmetric threats that could still inflict damage on commercial and military vessels.

Environmental and humanitarian concerns compound the crisis. Potential oil spills from attacks or accidents threaten fragile marine ecosystems, while disrupted fuel and goods flows impact civilian populations in the region and beyond. NGOs have called for humanitarian corridors to ensure delivery of essential supplies.

As negotiations drag on, markets and governments watch closely for any breakthrough. Trump’s public comments, including controversial map renamings and strong rhetoric, have added volatility to an already tense situation. Iranian responses remain firm, with officials insisting on ending the US blockade before full reopening.

The Strait of Hormuz crisis serves as a stark reminder of how regional conflicts can ripple globally through energy arteries. For now, limited traffic continues under high risk, oil prices stay elevated, and diplomats work against the clock to prevent further escalation. Resolution remains elusive, with the world’s energy security hanging in the balance of this narrow but vital waterway.

Advertisement
Continue Reading

Business

Tronox wins secrecy battle against Alexander Cokic

Published

on

Tronox wins secrecy battle against Alexander Cokic

Rare earth miner and processor Tronox has won a permanent Supreme Court injunction against self-styled whistleblower Alexander Cokic.

Continue Reading

Trending

Copyright © 2025